Clinical trial
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System.
NCT01206933 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System.
- Lead sponsor
- George Washington University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- June 30, 2015
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c, chronic, human immunodeficiency virus (hiv)